Predicted protein targets (top 9)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | TLR4 | O00206 | 3/20 | 0.39 |
| ▸ | L3MBTL1 | Q9Y468 | 3/20 | 0.37 |
| ▸ | NPC1 | O15118 | 2/20 | 0.37 |
| ▸ | MAPT | P10636 | 1/20 | 0.33 |
| ▸ | RAB9A | P51151 | 1/20 | 0.33 |
| ▸ | CRBN | Q96SW2 | 1/20 | 0.31 |
| ▸ | PIK3CD | O00329 | 1/20 | 0.31 |
| ▸ | TRPA1 | O75762 | 2/20 | 0.30 |
| ▸ | TRPM8 | Q7Z2W7 | 2/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Menthone SCHEMBL6128521 | 1.00 | TLR4 (0.39) | TLR4L3MBTL1NPC1MAPTRAB9A | |
| Menthone SCHEMBL31264956 | 1.00 | TLR4 (0.39) | TLR4L3MBTL1NPC1MAPTRAB9A | |
| Rel-Menthone SCHEMBL1868327 | 1.00 | TLR4 (0.39) | TLR4L3MBTL1NPC1MAPTRAB9A | |
| Rel-Isomenthone SCHEMBL650578 | 1.00 | TLR4 (0.39) | TLR4L3MBTL1NPC1MAPTRAB9A | |
| Menthone SCHEMBL13255148 | 1.00 | TLR4 (0.39) | TLR4L3MBTL1NPC1MAPTRAB9A | |
| Menthone SCHEMBL21709 | 1.00 | TLR4 (0.39) | TLR4L3MBTL1NPC1MAPTRAB9A | |
| Menthone SCHEMBL901274 | 1.00 | TLR4 (0.39) | TLR4L3MBTL1NPC1MAPTRAB9A | |
| Rel-Menthone SCHEMBL21711 | 1.00 | TLR4 (0.39) | TLR4L3MBTL1NPC1MAPTRAB9A | |
| Menthone SCHEMBL12326763 | 1.00 | TLR4 (0.39) | TLR4L3MBTL1NPC1MAPTRAB9A | |
| Rel-Isomenthone SCHEMBL30797355 | 1.00 | TLR4 (0.39) | TLR4L3MBTL1NPC1MAPTRAB9A |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1513 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-12564550-B2 | Anti-dandruff composition | MANE KANCOR INGREDIENTS PRIVATE LIMITED (IN) | 2026-03-03 | — | — | US | claimed |
| US-20260007137-A1 | FRESHNESS ENHANCING LABELS, SHEETS, AND SACHETS | RYP LABS, INC. (US) | 2026-01-08 | — | — | US | claimed |
| US-12514798-B2 | Use of [6]-paradol for stabilization of cosmetic compositions | SYMRISE AG (DE) | 2026-01-06 | — | — | US | claimed |
| EP-4651713-A1 | PLANT TREATMENT COMPOSITIONS COMPRISING CHITOSAN-COATED EMULSIONS | Universität Münster (DE) | 2025-11-26 | — | — | EP | claimed |
| US-20250352444-A1 | Antimicrobial mixtures | SYMRISE AG (DE) | 2025-11-20 | — | — | US | claimed |
| US-20250325463-A1 | COMPOSITIONS (III) | SYMRISE AG (DE) | 2025-10-23 | — | — | US | claimed |
| US-12446586-B2 | Oil-based insecticidal and insect repellent compositions | S. C. JOHNSON & SON, INC. (US) | 2025-10-21 | — | — | US | claimed |
| EP-4623057-A1 | ENCAPSULATED FRAGRANCE COMPOSITIONS FOR PROVIDING, MODULATING OR INTENSIFYING A SCENT | Symrise AG (DE) | 2025-10-01 | — | — | EP | claimed |
| EP-4615941-A2 | SUBSTITUTED 1,3-DIOXOLAN-4-ONES AND 1,3-DIOXAN-4-ONES AS FRAGRANCE INGREDIENTS | BASF SE (DE) | 2025-09-17 | — | — | EP | claimed |
| EP-4598834-A1 | SYSTEMS AND METHODS FOR CARRIER SYSTEMS FOR CONTROLLED RELEASE DELIVERY IN PERISHABLE GOODS | RYP LABS, Inc. (US) | 2025-08-13 | — | — | EP | claimed |
| WO-2016049458-A1 | DELIVERY SYSTEMS COMPRISING MALODOR REDUCTION COMPOSITIONS | THE PROCTER & GAMBLE COMPANY (US) | 2016-03-31 | — | — | WO | claimed |
| WO-2016049404-A1 | SUBSTRATES COMPRISING MALODOR REDUCTION COMPOSITIONS | THE PROCTER & GAMBLE COMPANY (US) | 2016-03-31 | — | — | WO | claimed |
| WO-2016049398-A1 | FRESHENING COMPOSITIONS AND DEVICES COMPRISING SAME | THE PROCTER & GAMBLE COMPANY (US) | 2016-03-31 | — | — | WO | claimed |
| US-20160090557-A1 | SUBSTRATES COMPRISING MALODOR REDUCTION COMPOSITIONS | THE PROCTER & GAMBLE COMPANY | 2016-03-31 | — | — | US | claimed |
| US-20160090556-A1 | PRODUCTS COMPRISING MALODOR REDUCTION MATERIALS | THE PROCTER & GAMBLE COMPANY | 2016-03-31 | — | — | US | claimed |
| WO-2016049397-A1 | FRESHENING COMPOSITIONS AND DEVICES COMPRISING SAME | THE PROCTER & GAMBLE COMPANY (US) | 2016-03-31 | — | — | WO | claimed |
| WO-2016049394-A1 | CLEANING AND/OR TREATMENT COMPOSITIONS COMPRISING MALODOR REDUCTION COMPOSITIONS | THE PROCTER & GAMBLE COMPANY (US) | 2016-03-31 | — | — | WO | claimed |
| WO-2016049396-A1 | ANTIPERSPIRANT AND DEODORANT COMPOSITIONS COMPRISING MALODOR REDUCTION COMPOSITIONS | THE PROCTER & GAMBLE COMPANY (US) | 2016-03-31 | — | — | WO | claimed |
| WO-2016049407-A1 | ABSORBENT ARTICLE COMPRISING MALODOR REDUCTION COMPOSITIONS | THE PROCTER & GAMBLE COMPANY (US) | 2016-03-31 | — | — | WO | claimed |
| US-20160090555-A1 | CLEANING AND/OR TREATMENT COMPOSITIONS COMPRISING MALODOR REDUCTION COMPOSITIONS | THE PROCTER & GAMBLE COMPANY | 2016-03-31 | — | — | US | claimed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (4 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-12564550-B2 | Anti-dandruff composition | MDH1, IL17A, PPARD | TLR4 815/4885L3MBTL1 4101/4885NPC1 1558/4885 |
| US-20250352444-A1 | Antimicrobial mixtures | LRBA, MGLL, TAS2R50 | TLR4 1070/4885L3MBTL1 1553/4885NPC1 1669/4885 |
| US-20260007137-A1 | FRESHNESS ENHANCING LABELS, SHEETS, AND SACHETS | MYB, CASP1, PLIN1 | TLR4 3640/4885L3MBTL1 449/4885NPC1 194/4885 |
| US-20250325463-A1 | COMPOSITIONS (III) | NISCH, TAS1R3, TAS2R3 | TLR4 3336/4885L3MBTL1 3634/4885NPC1 4332/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.